Darkhorse Technologies

Darkhorse Technologies Overview

Founded 2005
Status Private
Latest Deal Type Early Stage VC
Investors 1

Darkhorse Technologies General Information


Developer of DNA polymerase intended to synthesize DNA molecules. The company's polymerase are lyophilized for DNA replication and usually works in pairs to create two identical DNA strands from a single original DNA molecule, enabling thermocycler to perform DNA testing in the field and to replicate 749 nucleotides per second.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • Nederland, CO
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Darkhorse Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 19-Jun-2007 Completed Generating Revenue

Darkhorse Technologies Executive Team (1)

Name Title Board Seat Contact Info
Bradley Parks Ph.D Chief Executive Officer & Chief Applications Scientist

Darkhorse Technologies Investors (1)

To view Darkhorse Technologies‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
TEDCO Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial